Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Genetic Test for Hereditary Colon Cancer

By HospiMedica staff writers
Posted on 10 Oct 2000
A new genetic test for colon cancer detects disease-causing mutations in two genes, MLH1 and MSH2, which are responsible for the majority of cases of hereditary colon cancer. More...
The risk of colon cancer in an individual is increased 40 times by one of these mutations, to about 80%, from just 2% for the general population.

The test, called Colaris, was developed by Myriad Genetics, Inc. (Salt Lake City, UT, USA) and utilizes the same DNA sequencing technology used in Myriad's tests for identifying the risk of breast and ovarian cancer. The company states that the technology provides the most accurate assessment of risk to patients based on their genetic makeup.

People who are at high risk for colon cancer, following a positive Colaris test, can have earlier and more frequent exams and have precancerous polyps removed, said Gregory Critchfield, M.D., president of Myriad Genetics. This course of action has the potential to totally prevent colon cancer.

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Hypodermic Syringe
SurTract™ Safety Syringe
Syringe Pump
SP50 Series
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.